In 1953, British researchers discovered that drivers of London’s double-decker buses were more likely to suffer a deadly heart attack than the more physically active conductors (1). Another study published five years later found that the risk of heart attack was higher among government clerks than postmen (2). These studies laid the foundation for the hypothesis […]
Can Low-Fat Be Salvaged? – An Update From the WHI Trial
A recent paper published in the American Journal of Clinical Nutrition provides updated results from the Women’s Health Initiative (WHI) Dietary Modification Trial (1). One of the questions raised is whether there is still hope for a low-fat dietary approach for the prevention of heart disease. The primary aim of the WHI Dietary Modification Trial was to […]
Evolocumab (Repatha) for Heart Disease – The FOURIER Trial – Success or Failure?
The eagerly awaited results of the FOURIER trial were recently presented at the Annual Meeting of the American College of Cardiology (ACC) in Washington DC and simultaneously published in the New England Journal of Medicine (1). The goal of FOURIER was to evaluate the efficacy and safety of evolocumab (Repatha), a PCSK9 inhibitor, among subjects with elevated risk […]
VLDL – The Role of Triglyceride-Rich Lipoproteins and Remnant Cholesterol
Knowing the role of VLDL (very low-density lipoprotein) and chylomicrons is a key factor in understanding how lipids (fats) and lipoproteins are involved in atherosclerotic cardiovascular disease (ASCVD). In the current era of adiposity and metabolic disease, VLDL has gained a bigger role than before and may help explain many of the disorders associated with the obesity epidemic such […]
Niacin (Nicotinic Acid, Vitamin B3) – Who Should Take Niacin?
Niacin (nicotinic acid), also known as vitamin B3, is one of eight known B vitamins. It has been used for decades to lower cholesterol and reduce cardiovascular risk. However, today its use is somewhat debated. Meat and fish are the richest sources of nicotinic acid followed by fortified enriched grain, vegetables, and yeast. Tuna, salmon, chicken, turkey, […]
Why LDL-Cholesterol May Be Overestimated on a Low-Carb, High-Fat (LCHF) Diet
Elevated LDL-cholesterol (LDL-C) is common among people who adopt a low-carb, high-fat (LCHF) lifestyle. That’s why many physicians and nutritionists remain doubtful when it comes to LCHF, despite overwhelming evidence that such a dietary approach improves several other lipid parameters, usually leads to weight loss and positively affects glucose metabolism. Several studies have shown that LDL-C constitutes a major risk factor for the […]
Adiposity, Adipokines, and Adiposopathy – Sick Fat Explained
By now, all of us should know that we are in the throes of an obesity epidemic. Worldwide, over 500 million people are believed to be affected (1). Obesity in children and adolescents is on the rise and so is type 2 diabetes. And, according to the media and the experts, this will have horrible consequences that ultimately will […]
GLAGOV – The Lipid Hypothesis Gains Ground
The results from the recent GLAGOV trial suggest that aggressive lowering of LDL-cholesterol with a PCSK9-inhibitor on top of statin therapy in patients with coronary artery disease may reduce atherosclerotic plaque burden. Although these results provide support for the lipid hypothesis and may have significant implications for the future of cardiovascular medicine, our eyes are still on safety and […]
Apolipoprotein E (ApoE)
Apolipoprotein E (ApoE) is one of the proteins the body uses to transport fats (lipids) in the bloodstream from one tissue or cell type to another. It is essential for healthy metabolism of cholesterol and triglycerides, two important types of fats the body has to deal with regularly. The relationship between ApoE and heart disease has been studied quite intensively in recent […]
High Carbohydrate Intake Worse than High Fat for Blood Lipids
Data presented at the World Heart Federation’s World Congress of Cardiology & Cardiovascular Health 2016 (WCC 2016) in Mexico City may radically change our perspective on how carbohydrates and different types of fats affect blood cholesterol and other lipid biomarkers. The presentation was based on data from the Prospective Urban Rural Epidemiological (PURE) study. The data have not been […]
Fructose Restriction – An Effective Lipid Intervention?
The association between lipid disorders and heart disease is well known. Medical checkups usually involve measurements of cholesterol and other lipid parameters, and most doctors advise their patients on how to improve their lipid pattern. Dietary interventions to lower the risk of heart disease commonly aim at reducing blood levels of cholesterol, LDL cholesterol in particular. This is […]
Do Lipid Biomarkers Like Cholesterol Predict Cancer Risk?
Lipid biomarkers are frequently used to assess the risk of heart disease. A simple blood test provides information about LDL-cholesterol (LDL-C) (1), commonly nicknamed the bad cholesterol and HDL-cholesterol (HDL-C) (2), often called the good cholesterol. Triglycerides are usually measured as well (3). For many different reasons, lowering LDL-C has become a primary target for the prevention of heart disease. Evidence […]
Familial Hypercholesterolemia (FH) is Not Detected by Measuring Cholesterol
Elevated blood cholesterol is a common reason why people see their doctor. Most of us have been told that high cholesterol increases the risk of cardiovascular disease, and we are usually urged to lower it by any means available. But, the problem is that high cholesterol is often harmless, and heart disease can occur in the absence of […]
Fructose – The Role of Fructose in Metabolic Syndrome and Heart Disease
Mark already ignores me. I think it is because I am in bed and I am a ‘stationary’ object, because once or twice at home when he saw me up and on the way to the toilet he evinced great interest at once. I am absolutely determined to check myself in any tendency to be […]
Low-Density Lipoprotein (LDL) in Atherosclerosis and Heart Disease
The death rate from coronary artery disease (CAD) has declined considerably over the last three decades, mostly because of better control of risk factors and advances in therapy. However, due to the aging of the population and better survival of those affected, the prevalence of the disease remains high. The current epidemic of obesity and type 2 diabetes will likely escalate the problem further. Atherosclerosis, […]
- 1
- 2
- 3
- 4
- Next Page »